Related Experiment Video

Updated: May 2, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

15.4K

Lipid, blood pressure and kidney update 2013

Maciej Banach1, Corina Serban, Wilbert S Aronow

  • 1Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Zeromskiego 113, 90-549, Lodz, Poland, maciej.banach@umed.lodz.pl.

International Urology and Nephrology
|February 28, 2014
PubMed

Insights

In 2013, significant advancements were made in managing dyslipidemia, hypertension, and kidney disease through new global guidelines and landmark trials. These updates impact clinical practice for cardiovascular risk and chronic kidney disease patient care.

Area of Science:

  • Cardiology
  • Nephrology
  • Endocrinology

Background:

  • 2013 saw major guideline releases and trial presentations in lipid disorders, blood pressure, and kidney diseases.
  • Key organizations like IAS, ESC/ESH, ADA, KDIGO, ACC/AHA, JNC 8, ASH/ISH, and ACP released significant updates.

Purpose of the Study:

  • To summarize the most important events and reports in lipid disorders, blood pressure, and kidney diseases from 2013.
  • To provide an overview of landmark trials and new clinical practice guidelines impacting cardiovascular and kidney health.

Main Methods:

  • Review of major international and national guidelines published in 2013.
  • Summary of key clinical trials presented at major cardiology and nephrology congresses in 2013.

Main Results:

  • New recommendations were issued for dyslipidemia management (IAS, KDIGO, ACC/AHA).
  • Updated guidelines were released for hypertension management (ESC/ESH, JNC 8, ASH/ISH).
  • Guidance on chronic kidney disease (CKD) management, including dyslipidemia and early-stage CKD, was updated (ADA, ACP, KDIGO).

Conclusions:

  • The year 2013 brought substantial changes to the clinical management of lipid disorders, hypertension, and kidney diseases.
  • These updates aim to improve patient outcomes by refining treatment strategies for atherosclerotic cardiovascular risk and CKD.

More Related Videos

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K
Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches06:51

Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches

Published on: September 5, 2025

778

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
854
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
5.1K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679